Advances in alternative pharmacotherapy of ADHD.

Simple item page
dc.contributor.authorPityaratstian, Nuttornen_US
dc.date.accessioned2009-05-27T18:47:34Z
dc.date.available2009-05-27T18:47:34Z
dc.date.issued2005-09-21en_US
dc.descriptionChotmaihet Thangphaet. 32 references.en_US
dc.description.abstractSeveral alternatives to psychostimulants have been developed and expanded the variability of the treatment of ADHD. Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity. Bupropion and venlafaxine seem potentially promising. Significant new options include norepinephrine reuptake inhibitors, such as atomoxetine, and possibly selective dopamine agonists. Central anticholinesterases, such as donepezil, may improve core ADHD symptoms.en_US
dc.description.affiliationChild Psychiatric Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.en_US
dc.identifier.citationPityaratstian N. Advances in alternative pharmacotherapy of ADHD. Journal of the Medical Association of Thailand. 2005 Sep; 88 Suppl 4(): S357-62en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/39859
dc.language.isoengen_US
dc.source.urihttps://www.mat.or.th/journal/all.phpen_US
dc.subject.meshAdrenergic alpha-Agonists --therapeutic useen_US
dc.subject.meshAntidepressive Agents, Tricyclic --therapeutic useen_US
dc.subject.meshAttention Deficit Disorder with Hyperactivity --drug therapyen_US
dc.subject.meshBupropion --therapeutic useen_US
dc.subject.meshClonidine --therapeutic useen_US
dc.subject.meshHumansen_US
dc.subject.meshIndans --therapeutic useen_US
dc.subject.meshPiperidines --therapeutic useen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleAdvances in alternative pharmacotherapy of ADHD.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Medical Association of Thailand